Adam Mostafa

Adam Mostafa is an accomplished financial executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chief Financial Officer at X4 Pharmaceuticals since September 2018, Adam also contributes as a Board Member and Chair of the Audit and Compensation Committees at both Satellos Bioscience Inc. and Precision Biologics, Inc. Previous roles include Chief Financial Officer at Abpro, Managing Director at Cantor Fitzgerald, and Vice President at CRT Capital Group, among others. Adam began a career in investment banking at Citi and has a Bachelor's Degree in Economics from Brown University.